🟣 It’s the final day of #PainAwarenessMonth, so what better time to spotlight the invisible burden many people with #MultipleSclerosis carry. A new study from our #MSResearch Flagship researchers found that 53% of over 1600 participants experience regular pain. 20% reported 5–10 different types.

Congratulations to Dr Yuan Zhou of our #MultipleSclerosis Flagship who expertly presented on his multi-omics approach to investigating the Epstein-Barr virus EBV-MS connection to the world stage at the International Multiple Sclerosis Genetics Consortium (IMSGC) meeting in Barcelona, Spain. #EBV #MS

👏Proud to see our MS Research Flagship researchers contribute to the EBV-MS consortium meeting at #ECTRIMS2025 in Barcelona—sharing ideas, bringing the Australian perspective, building global connections & advancing research into EBV’s role in MS. #MSResearch #EBV #MSAustralia #GlobalCollaboration

Can high-efficacy treatments improve outcomes for people diagnosed with #MultipleSclerosis later in life? Dr Yi Chao Foong @ycfoong.bsky.social from our #MSResearch Flagship explores this in his poster at #ECTRIMS2025 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025

What impact do #MultipleSclerosis treatments, particularly B cell therapies, have on Epstein-Barr virus activity? Our MS Research Flagship's Dr Chhavi Asthana presents her poster investigating that @ #ECTRIMS2025 🔗msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MSResearch

Our MS Research Flagship's Panteha Khaledi presents her poster at #ECTRIMS2025! Her study explores how the immune system’s T cells respond to Epstein-Barr virus (EBV) in people with #MultipleSclerosis 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MSResearch

Our MS Research Flagship's Himanshu Saraswat is at #ECTRIMS2025! His study investigated whether rare genetic variants in families with multiple MS cases could help explain MS risk. More 👇 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MultipleSclerosis #MSResearch

Dr Xin Lin from our MS Research Flagship is at #ECTRIMS2025! His poster reveals how genetic structural variation in complement component 4 affects risk of MS onset and disability progression. 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MultipleSclerosis #MSResearch

Our MS Research Flagship's Prof Bruce Taylor is at #ECTRIMS2025! His poster explores how genetic oxidative stress and low Mediterranean diet intake combine to influence MS onset risk. More 👇 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MultipleSclerosis #MSResearch

In CDAH 3, over 3,100 participants were involved in clinical trials or via questionnaires during 2014-2019. Findings over the 40 years have helped to shape healthcare guidelines worldwide #Tasmania #CDAH@40 #medicalresearch

Former Menzies Director, Alison Venn, said that CDAH 2, from 2009-2011 about 3000 participants completed a survey, adding more longitudinal data to the study #CDAH@40 #medicalresearch #Tasmania

It was decided that the 1985 data could be used to find evidence of childhood lifestyle on adults. Record funding was granted, and about 80% of the original participants agreed to go through new testing, CDAH 1, where clinics were formed to gather new data. #CDAH@40 #medicalresearch

‪The study began in 1985, when 8,500 children had their health + fitness tested in the Australian School Health and Fitness Survey. Lifestyle, strength, blood pressure and skin fold tests formed some of the data captured said Professor Terry Dwyer, former Menzies Director #CDAH@40 #medicalresearch

Professor Seana Gall has welcomed guests to celebrate 40 years of the Childhood Determinants of Adult Health (CDAH) study - one of the most significant of its kind in Australia #CDAH@40 #medicalresearch #Tasmania

STOPstroke (Synergies TO Prevent stroke) is Australia’s 1st multi-disciplinary research initiative focused on preventing stroke. Recently, we hosted a workshop in Hobart- providing an opportunity for researchers to reflect on the program's impact + discuss the future of stroke prevention research.

🌟Give a little, change a lot. Help our researchers uncover the link between #multiplesclerosis & Epstein-Barr virus in an Australia-wide study.🧬 We need saliva samples from people with & without MS. Click here to check eligibility and participate 👉 redcap.utas.edu.au/surveys/?s=9... #MSresearch #EBV

Big shoutout to all the researchers, clinicians, and lived experience volunteers who made #ANZSOC2025 such a powerful event 💙 The energy, collaboration, and commitment to equity — especially from lived experience voices and local researchers — made this a truly inspiring gathering.

🫁 September is Pulmonary Fibrosis Awareness Month. ~1 million Australians live with this progressive lung disease. It causes lung scarring, breathlessness & chronic cough. Early diagnosis & treatment can slow progression. #PFAM2025 #PulmonaryFibrosis #LungHealth

📣 Would you like to keep up to date with multiple sclerosis research in Tasmania?✉️ Sign up for our MS Research Flagship's e-newsletter, featuring research findings, upcoming events, achievements of our world-class team and how YOU can get involved. Sep issue out now! 👇 createsend.com/t/j-A08713B4...

The #ANZSOC2025 conference brings together clinicians, researchers, policymakers, and people with lived experience to share knowledge and drive change. We’re proud to see members of our Lived Experience Advisory Group attend with Professor Gall to share our Cardiovascular Research Flagship's goals.

With Tasmania facing some of the highest stroke rates nationally, the #ANZSOC2025 conference provides a vital platform to explore the theme “Equity in Stroke” — focusing on improving care and outcomes, particularly in rural and regional communities like Tasmania.

Today, Hobart is proud to host over 330 stroke experts from across Australia and around the world for the Australian and New Zealand Stroke Organisation Conference (ANZSOC) 2025. The event is convened by Professor Seana Gall, lead researcher of our Cardiovascular Research Flagship. #ANZSOC2025

Curious about cardiovascular research? Sign up for our Cardiovascular Research Flagship’s newsletter to get updates on local projects, upcoming events, and the amazing work of our team. Check out the latest edition and subscribe: cardiovascularresearchflagship.createsend1.com/t/j-e-whitkk...

Want to turbo charge your #science career with a #PhD? Find out if people living with #MS are ageing well in this project at @menzies-research.bsky.social www.utas.edu.au/research/deg...

👏 Exciting news! Our MS Research Flagship's Prof Kaylene Young has been selected as a mentee in the Australian Academy of Health and Medical Sciences Mentorship Program, recognising her as an emerging leader in health & medical research. #MSResearch #multiplesclerosis #Leadership #HealthScience

🧪 Cold beers, warm company and brilliant science chat was the vibe at The Whaler and Hope & Anchor Scientists in the Pub events in Hobart last week as part of @beakerstreet Festival. Our red-coated 'roving scientists' sparked convos on brain signals, glaucoma MS & more. Tassie science at its finest!

It was a full house at our Menzies Research Update in Launceston! Despite the chill, the room was buzzing with updates on stroke, Parkinson’s, dementia & MND—plus a lively panel Q&A. Thanks to all who joined us! 💙 Keen to get involved? 🔗 www.utas.edu.au/menzies/get-...

What a day! Our 2025 #MultipleSclerosis Symposium at Menzies last week was full of fresh ideas, inspiring speakers & vibrant discussion. Huge thanks to our early-career researchers, keynote speakers, and everyone who joined us to share, learn & connect. A brilliant panel session topped it off!

We’re proud to see our MS Research Flagship’s Consumer & Community Reference Committee featured by NHMRC as a case study in meaningful consumer involvement in research. 🙌 Check it out 👇 🔗 www.nhmrc.gov.au/about-us/con...

🎙️MS Australia's latest Raw Nerve podcast features our MS Research Flagship's @lauralaslettphd.bsky.social discussing her new Incubator Grant supporting research into the use of wearable tech to better understand sleep + symptom variability in people with #MS 👇 www.msaustralia.org.au/raw-nerve/20...

Thanks to MS Australia for funding my research into the contributions of pericytes to MS development and progression. Can't wait to get started!

Thank you MS Australia for awarding me funding so that I can find out whether assessing #sleep and symptoms using smart watches and symptom trackers is acceptable and feasible to people living with #MS over longer periods of time.

🎉Congratulations to our MS Research Flagship's Dr @lauralaslettphd.bsky.social who has been awarded an MS Australia Incubator Grant. Laura is investigating whether smartwatches and the MySymptoMS app can effectively monitor sleep & symptoms in people with #multiplesclerosis over extended periods ⌚🛌

👏 Congrats to our MS Flagship's Dr @alastairjfortune.bsky.social who has been awarded an MS Australia Incubator Grant. His project will explore whether pericytes, brain vascular cells that regulate blood flow and communicate with immune cells, play a role in the early stages of #multiplesclerosis 🔬🧠

🌟July community engagement spotlight: our MS Research Flagship's Dr Bennet McComish @drmcstrange.bsky.social visited with U3A Kingborough to share about his work in evolutionary medicine, specifically how natural selection has shaped the genetics of autoimmune diseases such as #multiplesclerosis 🧬

📢 Our MS Research Flagship's June newsletter is out now! To find out more about its World MS Day celebrations, new courses, events with the MS community and the lived experiences driving its research forward, go here 👇 createsend.com/t/j-82439934...

👋 We're excited about connecting with our community on Bluesky go.bsky.app/82r1ofL